by guest www.bloodjournal.org From 2 KEY POINTS 1. Human Arterial Ring assay is an innovative system for the three-dimensional study of tumor angiogenesis 2. This assay can be exploited for anti-angiogenic drug screening and gene function analysis on human vessels.
We also performed targeted gene knock-down on this model by directly infecting explanted umbilical arteries with lentiviruses carrying short-hairpin RNA. Downregulation of VEGFR2 resulted in a significant reduction of the sprouting capability, demonstrating the relevance of human vascular explants for functional genomics studies.
Furthermore, a modification of this assay led to development of a three-dimensional model of tumor-driven angiogenesis, in which angiogenic outgrowth was sustained by spheroids of prostate cancer cells in absence of exogenous growth factors.
The human arterial ring assay bridges the gap between in vitro endothelial cell and animal model, and is a powerful system for identification of genes and drugs that regulate human angiogenesis.
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INTRODUCTION
Significant progress in angiogenesis research has been made following observations that a neoplastic mass does not grow above a few millimeters in diameter without recruiting new vessels 1, 2 . Numerous cellular and animal models have been developed to design robust and exhaustive assays able to mechanistically decipher the angiogenic cascade and to validate new anti-angiogenic drugs. Endothelial cell (EC) assays can mimic individual steps of the angiogenic cascade, such as cell migration, proliferation and capillary-like formation [3] [4] [5] . However, different cell types, such as fibroblasts, pericytes and smooth muscle cells, play a crucial role during new vessel formation by releasing soluble factors and establishing homotypic and heterotypic interactions. In addition, collective cell migration and extracellular matrix invasion are critical steps in the angiogenic process, but are difficult to investigate with cultured cells 6 . Characterization of angiogenesis has therefore mainly been established using animal models. However, although powerful insights into the molecular and cellular mechanisms of angiogenesis have been elucidated by means of transgenic and knock-out mouse models 2, 6 , the complexity of animal models often limits detailed mechanistic interpretation of experimental findings. Moreover, the contribution of inflammatory cellular infiltrate and the discrepancy between developmental and adult angiogenesis complicate the understanding of in vivo models 7 .
A functional solution to bridge the gap between endothelial cultured cells and in vivo animal models, is the use of ex vivo assays, in which explants of vascular tissues are embedded in extracellular matrix gels, and produce new vascular sprouts that differentiate in capillary-like structures. Rat and mouse aortic ring (AR) assays are frequently used to evaluate the efficacy of pro-and anti-angiogenic molecules, and the effect they have on different genetically-modified mouse lines. Adaptations of this assay allow direct
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From 4 monitoring of the angiogenic process and the study of endothelial tip cell dynamics [8] [9] [10] [11] . However, rat and mouse AR models display certain disadvantages, namely: a high ageand strain-dependent variability of assays 12 , as well as variations due to region of the explanted aorta 13 ; autonomous angiogenic outgrowth, limiting studies on pro-angiogenic factors 14 ; the necessity to sacrifice animals; and finally, the failure to detect speciesspecific anti-angiogenic compounds in preclinical screening assays 15 .
In this study, we developed an ex vivo three-dimensional (3D) assay of sprouting angiogenesis with arterial explants from human umbilical cords. This assay can be exploited for anti-angiogenic drug screening and, when coupled with lentiviral-mediated gene expression, for direct gene function analysis on developing human vessels.
Moreover, we provide evidence that tumor cells are able to autonomously sustain the development of vascular structures.
METHODS

Human arterial ring (hAR) angiogenesis assay
Umbilical cords from healthy women were kindly provided by the Sant'Anna and Mauriziano Hospitals, Torino, under the approval and the institutional guidelines of the University of Torino Ethical Committee and in compliance with the international laws and policies. Human umbilical arteries were explanted from umbilical cords (Supplemental Video 1), fibro-adipose tissue was dissected away (Supplemental Video 2) and they were sectioned in 1-2 mm-long arterial rings (Supplemental Video 3). Arterial rings were placed on 48-well culture dishes pre-coated with 100 µl of Basement Membrane Extract (8 mg/ml, regular BME Matrigel 
Whole-mount immunofluorescence staining
hARs were cultured in BME gel drop on glass bottom dishes (WillCo Wells). They were then equilibrated in PBS and fixed with zinc-buffered formalin overnight. After sample permeabilization with 0.2% Triton-X100 for 2 hours and saturation with 10% donkey serum for 1 hour, primary antibodies -rabbit anti-NG2 (1:100, Chemicon), goat antiVEcadherin (1:100, Santa Cruz Biotechnology) and rabbit anti-VEGFR2 (1:100, Cell 
Ac-LDL uptake
Incorporation analysis of Alexa-488-conjugated acetylated low-density lipoprotein (Ac-LDL 488; Invitrogen) was performed to assess the uptake ability of angiogenic outgrowth, as previously described 16 . hARs were incubated with 15 µg/ml of Alexa-488 Ac-LDL or Alexa-488 10000kDa Dextran (Invitrogen) in EGM ® -2 for 4 hours at 37 °C and washed three times with PBS. For live nuclear cell detection, hARs were incubated with cellpermeant nucleic acid stain (Syto63, Invitrogen). Ac-LDL uptake was observed in live hARs using a confocal laser-scanning microscope.
Computer assisted image analysis
Brightfield photomicrographs were modified by Image Pro Plus, as shown in Supplemental Fig. 3A . Kernel well.7x7 (strength: 7 pixels) filter makes binary-like modification of the images without user-defined threshold selection. After Kernel modification, capillary-like structures were selected by WinRhizo Pro (Regent Instruments Inc.), image analysis software studied to recognize elongated particles ("threshold"= 120; "image smoothing "= medium; "length/width ratio"< 4;
"background"= black). Angiogenic sprouting capability was quantified as total sprouts length (sum of every sprouts from each hAR), normalized with the control. This image analysis process was a completely automatic quantification of angiogenic sprouting For 3D rendering, after digital background subtraction and blind deconvolution using ImageJ plugins, high-resolution confocal image stacks of whole-mount hARs stained with anti-VEcadherin Ab were reconstructed by isosurface rendering using Imaris software (version 6.3.0, Bitplane, AG). Isosurface rendering is a computer-generated representation of a specified range of fluorescence intensities in a data set that allows the creation of an artificial solid object of a specific area. 9 . In brief, thoracic aortas were removed from 8-12
Angiogenic drug treatment experiments
week-old wild type C57/BL6 mice (Charles River) and fibro-adipose tissue was dissected away. Aortas were sectioned into 1mm-long aortic rings and incubated for 2 days in serum-free medium with antibiotics. Forty-eight-well culture dishes were coated with 100 µl of BME (8 mg/ml, regular BME Matrigel 
RESULTS
Establishment of the human arterial ring (hAR) angiogenesis assay
To develop three-dimensional hAR cultures, we explanted arteries from human umbilical cords (Supplemental Video 1) and carefully dissected them by removing the peri-arterial fibro-adipose tissue (Fig. 1A and Supplemental Video 2). We transversely cut the artery, to generate rings (Supplemental Video 3), which were then embedded in basement membrane extract (BME) gel (Fig. 1A) . These AR cultures were maintained in culture medium (EGM ® -2) and outgrowth began from around day 8 to 12. Sprouting cells formed capillary-like structures, which continued to grow and branch until day 30. Microscopic analysis of these multi-cellular structures showed that their mean diameter was 8.3±2.2 μ m (Supplemental Fig. 1A ), resembling the mean diameter of human capillaries 17 . Unlike mouse and rat aortic rings, which autonomously produce capillary-like structures 14, 18 , hARs only sprouted in the presence of angiogenic growth factors (GF) (Fig. 1A) .
However, no EC outgrowth was observed without the prior removal of peri-arterial fibroadipose tissue (Fig. 1A) .
To characterize these capillary-like structures, we performed whole-mount staining with an anti-vascular endothelial (VE)-cadherin Ab, a marker of mature EC. Confocal microscopy analysis showed that the majority of outgrowing cells were VE-cadherin positive, while three-dimensional rendering showed the complexity of the vascular network ( 1D and Supplemental Fig. 1C ). Moreover, in some regions of the tubular structures, NG2-positive cells were clearly visible (Fig. 1E ). NG2 is a well-characterized marker of mural cells 21 , thus suggesting that mural cells surround the capillary-like structures.
Immunohistochemical analysis unveiled two putative sources of EC that were contributing to vascular outgrowth. Arterial lumen-derived CD31-, CD34-, and VEcadherin-positive cells invaded the tunica intima and migrated outwards towards the BME gel. Furthermore, we detected VEGFR2/TIE2-positive cells in the external layer of hARs (Supplemental Fig. 2A-B) . After 15 days of stimulation, multi-cellular structures were detected, sprouting from this external layer and contributing to the vascular network (Supplemental Fig. 2A-B ).
Sensitivity to angiogenic factors
One of the major limitations of three-dimensional sprouting assays has been the challenge of outgrowth quantification. Here we developed a computer-assisted image analysis method, which automatically measured the length and area of angiogenic outgrowths (Supplemental Fig. 3A ). Using this quantification method, we measured the hAR response to different angiogenic GFs. hARs were cultured in basal medium with different growth factors. While vascular endothelial growth factor A (VEGF-A) and epidermal growth factor (EGF) significantly stimulated hAR outgrowth, others GFs such as basic fibroblast growth factor (FGF2), and insulin-like growth factor (IGF-1), were not able to significantly induce endothelial sprouting ( Fig. 2A-B) . The complete culture medium 12 (EGM ® -2), containing all these GFs, was slightly more efficient in inducing sprouting than VEGF or EGF alone at 50 ng/ml ( Fig. 2A-B ).
Moreover, we followed outgrowth dynamics in time-course experiments and observed a sigmoidal growth curve, characterized by sprout degeneration after 20 days of culture (Fig. 2C) . In the velocity-time graph, the maximum growth velocity was achieved at 14 days after BME embedding (Fig. 2D) .
Differently from murine aortas, which are explanted and immediately processed, umbilical cords can be preserved at 4°C for days after clamping. However, a reduction in sprouting efficiency (40%) was observed when arteries were processed from umbilical cords more than 2 days after clamping (Supplemental Fig. 4A-B) .
Anti-angiogenic drug validation
To evaluate the quality and reproducibility of the hAR assay, we calculated the Z′-factor, a statistical value designed to reflect the dynamic range of the assay as well as the variation associated with signal measurements (Supplemental Fig. 5A ) 22 . Z′-test on EGM ® -2 (positive control) and EBM ® -2 (negative control) cultured hARs unveiled that the Z′-factor for the hAR assay was 0.526 ( Supplemental Fig. 5B ); whilst the Z′-factor for the mAR assay -a widely used ex vivo assay in angiogenesis studies [8] [9] [10] [11] -was 0.353 (Supplemental Fig. 5C ). Therefore, under similar experimental conditions hAR is a more effective assay than mAR (Supplemental Fig. 5B-C) . Furthermore, we performed a prospective statistical power analysis in order to calculate the minimum sample size required to obtain at least 50% of the sprouting length with a confidence level of 0.05. We calculated that six hARs were required to obtain a statistical power of 0.80, which is the standard for adequacy. This sample size was therefore used in all of our experiments.
To explore the suitability of the hAR assay for testing anti-angiogenic drugs, we treated hARs with different classes of drugs undergoing preclinical trials or those approved for 6D ). Therefore, the hAR model proved to be twice more sensitive to the tested angiogenic inhibitors than the mAR model (Fig. 3B ).
Ex-vivo human gene knock-down
Gene silencing technology has considerably improved medical and biological research, but has rarely been applied to human tissues. We performed a gene target knock-down on hARs by directly infecting explanted umbilical arteries with lentiviruses carrying short hairpin RNA (shRNA). To set up the ex vivo lentiviral transduction and evaluate infection efficiency, we infected human arterial rings with a GFP-producing lentivirus. Confocal microscopy analysis showed that most of the cells constituting the vascular outgrowths were fluorescent, indicating that quiescent arterial EC were efficiently infected by
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From lentiviruses (Fig. 4) . The most efficient infection was achieved using 2x10 6 viral particles per hAR for 48 hours (Supplemental Fig. 7A) . Interestingly, the time-course 3D imaging showed that angiogenic outgrowth originated both from lumens and external layers of hAR (Fig. 4) , as suggested by IHC analysis (Supplemental Fig. 2B-C) .
To evaluate the effects of gene silencing in hARs, we targeted VEGFR2, being the crucial gene for modulating angiogenic processes. We selected the shRNA-targeting VEGFR2 by screening EC from umbilical cord veins (Supplemental Fig. 8A-B ). hARs were infected with the two most efficient VEGFR2-silencing shRNAs (shVEGFR2_87 and shVEGFR2_88), or scramble shRNA (shSCRL) as a control, and VEGFR2 expression was evaluated on EC extracted from the gel ( Fig. 5A and Supplemental Fig. 9A-B) . Both shVEGFR2_87 and shVEGFR2_88 were effective in reducing VEGFR2 levels compared to scramble shRNA ( Fig. 5A and Supplemental Fig. 9A-B ). hARs infected with shVEGFR2_87 and shVEGFR2_88 demonstrated significantly reduced growth of capillary-like structures compared to shSCRL (Fig. 5B-C) .
The VEGFR2 knockdown results in hARs were then compared with the mAR model.
VEGFR2 knockdown efficiency was evaluated (Fig. 5D) following transduction with the two most effective shRNAs for silencing mouse VEGFR2 (Supplemental Fig. 8C-D ) in mARs. Gene silencing of VEGFR2 in mARs resulted in a significant reduction of sprouting capability (Fig. 5E-F) , similar to that obtained in hARs.
These results show that, by coupling lentiviral-mediated gene silencing with ex vivo human models, it is possible to perform functional genetic studies directly on human explants.
A three-dimensional model of tumor-driven angiogenesis
Tumor cells elicit angiogenesis through the production of pro-angiogenic factors, such as VEGF
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. We investigated whether tumor cells were able to sustain the formation of . In addition, these cells showed the ability to grow as 3D spheroidal aggregates of tumor cells (STC) in BME gel, which recapitulate several features of tumor progression 33 . Angiogenic outgrowth was stimulated in hARs that were embedded in BME gel, together with STC, cultured in the absence of GFs. The sprouting process started after 20-25 days and reached maximal outgrowth at day 30-35 ( Fig. 6A ).
In addition, STC synergized with exogenous angiogenic factors to support the formation of capillary-like structures (Fig. 6B ). Angiogenic outgrowth, stimulated by the culture medium, was strongly increased by the presence of STCs, with a considerable gain in sprout length, observable after 15-18 days of culture (Fig. 6C) . Moreover, the capillarylike structures formed in presence of STC were more branched than in presence of complete medium alone (Fig. 6D) . In order to exclude the contribution to angiogenic outgrowth of potentially protruding STC we observed this process in time-lapse microscopy. Capillary-like structures were clearly derived exclusively from hAR (Supplemental Fig. 10A ). In some experiments STC were transduced with DsRed and visualized by fluorescent microscopy showing compact aggregate of cells never producing protruding structures (Supplemental Fig. 10B) . A partial directionality of the capillary-like structures towards the STC was observed, although endothelial sprouts were also present in the opposite region of the hARs (Fig. 6A-B) . We evaluated the sensitivity of this tumor-driven angiogenesis model by treating the co-cultures with the antiangiogenic drug Sunitinib. Interestingly, Sunitinib treatment was less effective in hARs co-cultured with STC compared to hARs alone (Fig. 6E) . The three-fold difference of IC50 in response to Suntinib between hARs (0.49 nM) and STC-hARs (1.76 nM) may possibly be explained by other angiogenic factors produced by STC.
DISCUSSION
The intrinsic complexity of vessel sprouting limits the efficacy of cellular in vitro assays in elucidating molecular, cellular and pharmacological mechanisms [3] [4] [5] [12] [13] [14] [15] 26 . In this study, we describe a reproducible system for investigating the angiogenic cascade by controlling experimental variables and precisely quantifying angiogenic outgrowth. We developed a human angiogenesis model, in which umbilical artery rings embedded in BME produced capillary-like structures, recapitulating different steps of angiogenesis, including EC sprouting, migration and differentiation into capillaries. Contrary to previously described similar assays, i.e. those involving rat and mouse aortic rings, which autonomously form capillary-like structures when matrix-embedded, vessel outgrowth of hARs is completely dependent on the addition of angiogenic factors in the culture medium. Specifically, the presence of VEGF is required for endothelial sprouting from hARs while VEGFR2 inhibition completely blocks this process. In contrast to FGF2, and IGF-1, which do not directly control endothelial outgrowth, high concentration of EGF efficiently induces this process.
Three-dimensional culture models are often restricted by difficulties in achieving unbiased and reproducible quantifications. To overcome this limitation, we developed a computer-assisted image analysis strategy to quantify angiogenic outgrowth. Our experiments with anti-angiogenic drugs demonstrated the power of this assay to quantitatively evaluate their inhibitory effects at different steps of the angiogenic cascade.
In addition, the higher sensitivity to angiogenic inhibitors compared to other assays (for example cultured cells or mAR) suggests the possibility of exploiting these hAR assays for screening new anti-angiogenic drugs. As such, the assay is particularly applicable to biological therapeutics (such as antibodies and ligand traps) that cannot be studied in mice
org From due to their specificity for human targets. The reproducibility and robustness of this assay make it a versatile tool for pre-clinical angiogenesis studies in parallel with animal trials.
A major potential application of the hAR assay is the investigation of the impact of gene loss-of-function on human angiogenesis through exploitation of lentiviral-mediated RNA interference. As proof-of-principle, we down-regulated VEGFR2 in hAR, obtaining a significant reduction of the sprouting capability, thus demonstrating the possibility of performing functional genomics studies directly on human vascular explants. So far, ex vivo studies of gene deficiency were limited by the lack of availability of genetically modified mice. This system however allows the study of all human genes potentially involved in the process of angiogenesis and can therefore be exploited as a tool to identify biomarkers and to monitor the efficacy of anti-angiogenic regimens and the onset of resistance 34 .
Frequently 3D models of angiogenesis tend to focus on the process itself, only including EC or co-cultures with mesenchymal mural cells, without including direct interactions with a tumor component. In this study, we developed an ex vivo model where angiogenesis can be investigated under the direct influence of the tumor microenvironment. Spheroids of prostate cancer cells embedded in BME sustain the angiogenic outgrowth from hAR in the absence of exogenous growth factors. We did not investigate which STC-produced growth factors are involved in this angiogenesis process, but interestingly the STC-induced outgrowth was more resistant to VEGFR2 inhibition.
This assay is one of the first examples of an autonomous system that does not require continuous exogenous stimulation. Interestingly, in this tumor hAR model, there is occasional direct contact of tumor cells with EC. The significance of these contacts and how they eventually develop is unknown and thus requires further investigation.
However, the possibility of dynamic observation of tumor cells which recruit, interact and
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stimulate the growth of new vessels can greatly further our understanding of tumor-driven angiogenesis.
In conclusion, human Arterial Ring assay is an innovative system for the 3D study of human angiogenesis. This model allows (i) identification of new candidates that regulate sprouting angiogenesis; (ii) screening for pro-or anti-angiogenic drugs; (iii) employment of shRNA gene silencing directly on human sprouting angiogenesis; (iv) dynamic analysis of tumor microenvironmental effects on vessels. 
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